References

medalphabet

Медицинский алфавит

Medical alphabet

2078-56312949-2807

ООО «Альфмед»

medalphabet-303

Research Article

Статьи

Некоторые аспекты проблемы рака шейки матки в мире и в Республике Армения

Some aspects of cervical cancer problems in world and Republic of Armenia

Куджоян

Л. С.

Kujoyan

L. S.

noemail@neicon.ru

Роговская

С. И.

Rogovskaya

S. I.

noemail@neicon.ru

Национальный институт здравоохранения имени академика Авдалбекяна Минздрава Республики АрменияРоссияNational Institute of Public Health, YerevanRussian Federation

ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияMedical Academy for Continuing Professional EducationRussian Federation

2017

27072017

323

Современная гинекология

5052

2017

Куджоян Л.С., Роговская С.И.

Kujoyan L.S., Rogovskaya S.I.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.med-alphabet.com/jour/article/view/303

Проблема рака шейки матки (РШМ) в течение многих десятилетий продолжает оставаться актуальной. По прогностическим оценкам экспертов (с учетом роста населения и увеличения ожидаемой продолжительности предстоящей жизни), к 2020 году в развивающихся странах рост показателей заболеваемости и распространенности РШМ составит около 40 %, а в развитых странах - 11 %. Общеизвестен факт, что если сегодня не проводить своевременные мероприятия по профилактике и лечению РШМ, то после 2050 года ежегодно в мире РШМ будут заболевать 1 млн женщин. Согласно международным данным уровень смертности от РШМ в Армении по сравнению с РФ и некоторыми европейскими государствами (например, Румынией) в три раза ниже, но все же почти в три раза выше, чем в Финляндии, Бельгии, Швеции. Для раннего выявления РШМ необходимы адекватные программы скрининга. Их успешное проведение зависит как от повышения уровня информированности населения относительно ранних признаков и симптомов онкологических заболеваний, так и от поэтапной работы медперсонала с целью взятия на учет пациентки с выявленной патологией и ее ведения в соответствии с протоколом.

The problem of cervical cancer for many decades continues to be the focus of the world s outstanding oncologists. According to the predictive estimations of experts (taking into account the population growth and the expected life expectancy increase), by 2020 in developing countries, the incidence and prevalence of cervical cancer will be about 40 %, and in developed countries about 11 %. It is a well known fact that if today we don ’t carry out up-to-date measures for the prevention and treatment of cervical cancer, after 2050, each year in the world 1 million women will have cervical cancer. According to the international data, death rate from cervical cancer in Armenia is 3 times lower compared to Russia and some European countries (i.e. Romania), but still almost 3 times higher than in Finland, Belgium, Sweden. For early detection of cervical cancer, screening programs are necessary. Their successful implementation depends on both increasing the level of awareness of the population about the early signs and symptoms of cancer, and on the step-by-step work of medical personnel with the aim of promptly taking the patient on record and keeping it in accordance with protocol.

рак шейки маткискрининг

cervical cancerscreening

References1

Аксель Е. М. Статистика злокачественных новообразований женской половой сферы // Онкогинекология 2012; 1: 18-23.

Здоровье и здравоохранение. Статистический ежегодник, 2016, МЗ РА.

Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность}. // М: ФГБУ «МНИОИ им. П. А. Герцена» Минздрава России. 2014.

Новик В. И. Скрининг рака шейки матки. // Практ. Онкол. 2010; 11: 2: 66-73.

Материалы с сайта www.demographia.ru.

Профилактика рака шейки матки: Руководство для врачей. Под. ред. Г. Т. Сухих, В. Н. Прилепской. М. 2012.

Роговская С. И., Подзолкова Н. М. Профилактика рака шейки матки.Современные стратегии // Доктор РУ. Прил. по онкологии.- 2011.- № 2.- С. 24-27.

Шейка матки, влагалище, вульва. // Физиология / патология / кольпоскопия /эстетическая коррекция: руководство для практикующих врачей.- под ред. С. И. Роговской, Е.В. Липовой. 2014.

Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003 (http://www.who.int/chp/knowledge/ publications/adherence_full_report.pdf, accessed 1 October 2016}.

Ambroggi M, Biasini C, DelGiovane C, FornariF, Cavanna L. Distance as a barrier to cancer diagnosis and treatment: review of the literature. The Oncologist. 2015; 20 (12): 1378-85.

Arbyn M., Sasieni P., Meijev C.J. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV-test positivity rate. J. Cell Mol. Med. 2009; 13: 648-659.

Assessing national capacity for the prevention and control of noncommunicable diseases: global survey. Geneva: World Health Organization; 2016 {http://apps.who.int/iris/bitstr eam/10665/246223/1 /9789241565363-eng.pd-f?ua=1, accessed 1 October2016}.

Balogh EP, Ganz PA, Murphy SB, Nass SJ, Ferrell BR, Stovall E. Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine workshop. The Oncologist. 2011; 16 (12): 1800-5.

Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A et al. Planning and developing population-based cancer registration in low- and middle -income settings. Lyon: International Agency for Research on Cancer {IARC Technical Publication No. 43}; 2014 {http://www.iarc.fr/en/publications/ pdfs-online/treport-pub/treport-pub43/IARC_ T echnical_Report_No43.pdf, accessed 1 October2016}.

Brotherton J. M., Fridman M., May C. L. et al. // Lancet.- 2011.- Vol. 377, N 9783.- P. 2085-2092.

Cancer control: diagnosis and treatment. WHO Guide for effective programmes. Geneva: World Health Organization; 2008 (http://apps.who.int/ iris/bitstream/10665/43827/1/9789241547406_ eng.pdf, accessed 1 October2016}.

Cancer control: early detection. WHO Guide for effective programmes. Geneva: World Health Organization; 2007 (http://apps.who.int/ iris/bitstream/10665/43743/1/9241547338_eng. pdf, accessed 1 October 2016}.

Cancer control knowledge into action. WHO guide for effective programmes. Geneva, World Health Organization, 2006.

Cancer control: policy and advocacy. WHO Guide for effective programmes. Geneva: World Health Organization; 2008 {http://apps.who.int/ iris/bitstream/10665/43995/1 /9241547529_ eng. pdf, accessed 1 October 2016}.

Cancer control: prevention. WHO Guide for effective programmes. Geneva: World Health Organization; 2007 {http://apps.who.int/iris/ bitstream/10665/43575/1/9241547111_eng. pdf, accessed 1 October 2016}.

Crusswell J. M., Rancoholf D.F., Rramer B.S. Principles of cancer screening: Lessons from history and study design issues. Semin. Oncol. 2010; 37: 202-215.

Designing health financing systems to reduce catastrophic health expenditure. Technical briefs for policy-makers. Geneva: World Health Organization; 2005(WHO/EIP/HSF/PB/05.02; http://www.who.int/health_financing/pb_2. pdf, accessed 1 October 2016}.

Donovan B., Franklin N., Guy R. et al. // Lancet Infect Dis.- 2011.- Vol. 11, N 1, P. 39-14.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013 {http://globocan.iarc.fr, accessed 1 October 2016}.

Garland S M. Cervical Cancer and other HPV-related diseases: Asia Oceania perspective // The 27th International Papillomavirus Conference, 17-22 September, 2011, Germany.- Berlin; 2011 www.hpv2011.org.

Giuliano AR. Prevention of Invasive Cervical Cancer in US: Past, Present and Future, Ph D. // The 27th International Papillomavirus Conference, 17-22 September, 2011, Germany.- Berlin; 2011.- www.hpv2011.org.

Global health observatory: the data repository [website]. Geneva: World Health Organization; 2017 (http://www.who.int/gho/database/en, accessed 30 January 2017.

GLOBOCAN.- 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base N 10. Lyon, France: International Agency for Research on Cancer.-2010. - www.hpv2011.org.

Guide to cancer early diagnosis ISBN 978-92- 4-151194-0 World Health Organization 2017.

Health literacy: the solid facts. Copenhagen: WHO Regional Office for Europe; 2013 (http://www.euro.who.int/_data/assets/ pdf_file/0008/190655/e96854.pdf, accessed 1 October 2016

International Agency for Research on Cancer (IARC} and World Health Organization} Cervical cancer screening. IARC Handbooks of cancer prevention Vol. 10. Lyon, IARC Press, 2005.

Knaul K, Horton S, Yerramilli P, Gelband H, Atun R. Financing cancer care in low-resource settings. In: Gelband H, Jha P, Sankaranarayanan R, editors. Cancer: disease control priorities, 3rd edition, volume 3. Washington {DC}: International Bank for Reconstruction and Development/World Bank; 1 November 2015 (http://dcp-3.org/chapter/1360/financ-ing-cancer-care-low-resource-settings, accessed 1 October 2016}.

Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the Former Soviet Union, Caucasus region and Central Asia. Vaccine 2013;31S: H46-58.

Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015; 16 (12): 1231-72.

Sankaranarayanan R., Gaffikin L., Jacob M. A critical assessment of screening methods for cervical neoplasia. Int. J. Gynecol. Obstet. 2005; 89: 4-12.

Sasieni P., Castanon A., Cuzick J. Effectineness of cervical screening with age population based case-control study of prospectively recorded data. BMJ 2009; 339: 2963-2968.

WHO global strategy on people-centred and integrated health services. Geneva: World Health Organization; 2015 (http://www.who.int/ servicedeliverysafety/areas/people-centred-care/ global-strategy/en/, accessed 1 October.

The authors declare that there are no conflicts of interest present.